- Cancer-related molecular mechanisms research
- Endometrial and Cervical Cancer Treatments
- Molecular Biology Techniques and Applications
- Erythrocyte Function and Pathophysiology
- Acute Lymphoblastic Leukemia research
- Neurogenetic and Muscular Disorders Research
- Genetic factors in colorectal cancer
- Radiomics and Machine Learning in Medical Imaging
- Chronic Myeloid Leukemia Treatments
- Intracranial Aneurysms: Treatment and Complications
- Moyamoya disease diagnosis and treatment
- Erythropoietin and Anemia Treatment
- Chronic Lymphocytic Leukemia Research
- Cervical Cancer and HPV Research
- Autophagy in Disease and Therapy
- Pancreatic function and diabetes
- MRI in cancer diagnosis
- Cannabis and Cannabinoid Research
- biodegradable polymer synthesis and properties
- Neuroscience and Neuropharmacology Research
- Amyotrophic Lateral Sclerosis Research
- Intracerebral and Subarachnoid Hemorrhage Research
Tianjin Medical University Cancer Institute and Hospital
2024-2025
University of Chinese Academy of Sciences
2023
Institute of Psychology, Chinese Academy of Sciences
2023
Second Affiliated Hospital of Xinjiang Medical University
2022
Xinjiang Medical University
2022
Institute of Hematology & Blood Diseases Hospital
2021
Chinese Academy of Medical Sciences & Peking Union Medical College
2021
ZheJiang Institute For Food and Drug Control
2020
Weizmann Institute of Science
2019
Genetics, pathology, and molecular studies demonstrate that microRNA-218 is modulated might play a role in amyotrophic lateral sclerosis.
Erythropoietin (EPO) drives erythropoiesis and is secreted mainly by the kidney upon hypoxic or anemic stress. The paucity of EPO production in renal EPO-producing cells (REPs) causes anemia, one most common complications chronic nephropathies. Although mitochondrial dysfunction commonly observed several hematopoietic disorders, mechanism which quality control impacts anemia remains elusive. In this study, we showed that FUNDC1, a mitophagy receptor, plays critical role EPO-driven induced...
Intracranial aneurysmal subarachnoid hemorrhage (aSAH) is a dangerous and highly fatal condition if ruptured. Significant advances have been made in the treatment of unruptured intracranial aneurysms (UIAs), but risk assessment methods for early diagnosis aneurysm (IA) rupture remain limited.The datasets IA GSE13353, GSE15629, GSE54083 were downloaded through Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) ruptured identified by R software using such as gene set...